Vicus Capital’s Repligen RGEN Stock Holding History

Vicus Capital’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-876	Closed	-$253K	–	239
2021 Q3	$253K	Buy	+876	New	+$225K	0.04%	125

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vicus Capital's RGEN Position: Q4 2021 in Review

Vicus Capital sold out of Repligen (RGEN) in Q4 2021, closing a stake of 876 shares — an estimated $253K sold.

Vicus Capital first reported a position in RGEN in Q3 2021 and held it in 1 quarter. The position peaked at $253K in Q3 2021. 507 funds tracked by Wall St. Rank hold RGEN as of Q4 2021.

Vicus Capital reported no remaining Repligen position as of Q4 2021 after selling out during the quarter.
Vicus Capital sold 876 Repligen shares in Q4 2021, an estimated $253K.
Vicus Capital first reported a position in Repligen in Q3 2021 and held it in 1 quarter.
Vicus Capital's Repligen position peaked at $253K in Q3 2021.
507 funds tracked by Wall St. Rank held Repligen as of Q4 2021.

Based on Vicus Capital's 13F filing for Q4 2021, filed 10 Feb 2022.